ArticleJournal of the American Geriatrics Society2025
Household Wealth and Potentially Inappropriate Medications in Persons With Dementia: Role of Comorbidities and Caregivers.
Article in Journal of the American Geriatrics Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Champion-Led Deprescribing for Persons with Dementia in Primary Care: A Qualitative Study in Accountable Care Organizations.Journal of general internal medicine · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe association between lower socioeconomic status and increased potentially inappropriate medications (PIMs) among older adults, as seen in some studies, is infrequently studied in persons with dementia (PWD). This association may additionally be impacted by multimorbidity and caregiver support in PWD. Thus, we examined the association between wealth and PIMs in PWD and the effects of comorbidities and caregivers.
methodsWe included community-dwelling adults aged ≥ 66 with dementia in the Health and Retirement Study (2008-2018). PIMs included sedative-hypnotics, strongly anticholinergics, and medications from 2019 Beers and STOPP-Version 2 criteria. The primary outcome was a prescription for ≥ 1 PIM. We used logistic regression with national survey weights to examine the association between household wealth (above vs. below sample median) and ≥ 1 PIM through 4 models: (1) unadjusted, (2) adjusted for demographics (age, sex, race/ethnicity), 3) Model 2 + comorbidity count (range 0-7), (4) Model 3 + caregiver type (no caregiver, paid caregiver, unpaid caregiver only).
resultsThe cohort consisted of 1475 PWD (median age 84, 67% female, 15% Black, median household wealth $86,000 (IQR 2000-315,000), 49% with unpaid caregiver only, 23% with paid caregiver). Overall, 76% received ≥ 1 PIM. Adjusting for demographics, PWD with below median wealth showed increased odds of receiving ≥ 1 PIM (OR = 1.44, 95% CI = 1.07-1.93). This association was not statistically significant after adjusting for comorbidity count (OR = 1.26, 95% CI = 0.93-1.70). In a stratified analysis by comorbidity count adjusting for demographics and wealth, paid caregiver presence was associated with increased odds of PIMs among individuals with ≤ 2 chronic conditions (OR = 2.60, 95% CI = 1.44-4.69) but not with ≥ 3 chronic conditions (OR = 0.90, 95% CI = 0.50-1.62) (p = 0.02 for interaction).
conclusionsAmong PWD, the association between lower wealth and increased odds of PIMs was no longer statistically significant after adjusting for comorbidity count. Caregiving status had a complex relationship with PIMs based on comorbidity burden.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.